NMS-002 - Assessment of the safety and efficacy of romiplostim in live donor liver transplant recipients: A prospective randomised open label trial

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: NMS-002
• By: S NAIR, Anju (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, India)
• Co-author(s): Dr Anju S Nair (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, Kochi, India)
  Dr Seethalakshmy K D (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, Kochi, India)
  Dr Namitha Ranjith (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, Kochi, India)
  Dr Sreelekshmi R (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, Kochi, India)
  Dr Meenu Vijayan (Department of Pharmacy Practice, Amrita School of Pharmacy AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India, Kochi, India)
  Dr Anila K N (Department of Gastrointestinal Surgery and Solid Organ Transplant, Amrita Institute of Medical Sciences and Research Centre, Amrita University, Kochi, Kerala, India, Kochi, India)
  Dr Saraswathy S Nair (Department of Gastrointestinal Surgery and Solid Organ Transplant, Amrita Institute of Medical Sciences and Research Centre, Amrita University, Kochi, Kerala, India, Kochi, India)
  Dr Sudhindran S (Department of Gastrointestinal Surgery and Solid Organ Transplant, Amrita Institute of Medical Sciences and Research Centre, Amrita University, Kochi, Kerala, India, Kochi, India)
  
• Abstract:

  Introduction:
  Following live donor liver transplantation (LDLT), thrombocytopenia commonly occurs, with very low platelet counts portending significant morbidity and normalisation of platelet counts foretelling good graft function. Romiplostim, a thrombopoietin receptor agonist used in hematological thrombocytopenic conditions, has not been..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login